Natural History of Contralateral Nodules After Lobectomy in Patients With Papillary Thyroid Carcinoma

被引:18
|
作者
Ritter, Amit [1 ,2 ]
Bachar, Gideon [1 ,2 ]
Hirsch, Dania [2 ,3 ]
Benbassat, Carlos [2 ,4 ]
Katz, Orna [1 ,2 ]
Kochen, Nadav [1 ,2 ]
Diker-Cohen, Talia [2 ,3 ,5 ]
Akirov, Amit [2 ,3 ]
Shimon, Ilan [2 ,3 ]
Robenshtok, Eyal [2 ,3 ]
机构
[1] Beilinson Med Ctr, Rabin Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, IL-49100 Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-6997801 Tel Aviv, Israel
[3] Beilinson Med Ctr, Rabin Med Ctr, Endocrine Inst, IL-49100 Petah Tiqwa, Israel
[4] Assaf Harofeh Med Ctr, Endocrine Inst, IL-70300 Zerifin, Israel
[5] Beilinson Med Ctr, Rabin Med Ctr, Internal Med A, IL-49100 Petah Tiqwa, Israel
关键词
COMPLETION THYROIDECTOMY; ASSOCIATION GUIDELINES; LOW-RISK; CANCER; PREVALENCE; MICROCARCINOMA; MANAGEMENT; TIME;
D O I
10.1210/jc.2017-01616
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Bilateral thyroid nodularity is considered an indication for total thyroidectomy in papillary thyroid carcinoma (PTC). However, the natural history and outcome of contralateral nodules have never been studied. Objective: To investigate the natural history of nonsuspicious contralateral nodules after lobectomy for PTC. Methods: We included patients who had one or more solid nodules (>= 3 mm) in the contralateral lobe with benign cytology before surgery or small nonsuspicious nodules per ultrasonography. Results: One hundred and twelve patients were included. Median age was 57 years, and median size of the PTC (initial lobectomy) was 8 mm (range, 0.5 to 28 mm). On the contralateral side, the median size of nodules was 7 mm (range, 3 to 30 mm). Thirty-three nodules (29%) had fine-needle aspiration (FNA) before surgery, and all were benign. After a median follow-up of 6 years, median growth was zero (range, -20 to 19 mm). Twenty-six nodules (23%) increased >= 3 mm in size (median, 6 mm; range, 4 to 19 mm). Twenty patients (18%) developed new nodules. Twelve patients (11%) underwent completion thyroidectomy for growth (three), suspicious FNA (seven; Bethesda III to V), malignancy (one), or unknown reason (one). Overall, according to the completion thyroidectomy specimen, six patients (5%) were diagnosed with contralateral PTC (five micro-PTCs, one 20 mm), and all were without evidence of disease at the end of follow-up. There were no surgical difficulties or local complications during completion surgery. Conclusions: Lobectomy for low-risk patients with a small PTC and nonsuspicious contralateral thyroid nodule (s) is a reliable and safe initial treatment option. In the few patients who required completion thyroidectomy, treatment with surgery and radioiodine was effective.
引用
收藏
页码:407 / 414
页数:8
相关论文
共 50 条
  • [1] Outcomes of nonsuspicious contralateral nodules with active surveillance after lobectomy in patients with papillary thyroid carcinoma
    Huang, Hui
    Liu, Jie
    Wang, Xiaolei
    Liu, Shaoyan
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [2] Clinical implications of pathologic factors after thyroid lobectomy in patients with papillary thyroid carcinoma
    Park, Young Min
    Lee, Doh Young
    Oh, Kyung Ho
    Cho, Jae-Gu
    Baek, Seung-Kuk
    Kwon, Soon-Young
    Jung, Kwang-Yoon
    Woo, Jeong-Soo
    ORAL ONCOLOGY, 2017, 75 : 1 - 5
  • [3] Delphian lymph node metastasis predicts occult contralateral carcinoma for unilateral papillary thyroid carcinoma patients with contralateral benign nodules
    Chen, Min -Long
    Xu, Dong
    Yan, Xing-Qiang
    Xie, Bo-Jian
    ASIAN JOURNAL OF SURGERY, 2023, 46 (01) : 156 - 159
  • [4] Occult Contralateral Carcinoma in Patients with Unilateral Papillary Thyroid Microcarcinoma
    Koo, Bon Seok
    Lim, Hyun Sil
    Lim, Young Chang
    Yoon, Yeo-Hoon
    Kim, Yong Min
    Park, Yong Ho
    Rha, Ki-Sang
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (04) : 1101 - 1105
  • [5] Should Contralateral Nodules Be an Indication of Total or Completion Thyroidectomy for Patients With Unilateral Papillary Thyroid Carcinoma?
    Ma, Tengfei
    Wang, Haiyang
    Liu, Jifeng
    Zou, Jian
    Liu, Shixi
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [6] Predictive factors of contralateral occult carcinoma in patients with papillary thyroid carcinoma: a retrospective study
    Chen, Xiaohang
    Zhong, Zhenwei
    Song, Muye
    Yuan, Jiru
    Huang, Ziyang
    Du, Jialin
    Liu, Yongchen
    Wu, Zeyu
    GLAND SURGERY, 2020, 9 (04) : 872 - 878
  • [7] Contralateral Low-to-Intermediate Suspicion Nodule is Not a Contraindication for Lobectomy in Patients with Papillary Thyroid Carcinoma
    Pak, Shin Jeong
    Kwon, Douk
    Kim, Byung-Chang
    Cho, Jae Won
    Kim, Won Woong
    Lee, Yu-mi
    Sung, Tae-Yon
    Baek, Jung Hwan
    Kim, Won Gu
    Kim, Won Bae
    Chung, Ki-Wook
    THYROID, 2023, 33 (11) : 1339 - 1348
  • [8] Risk Factors for Contralateral Occult Papillary Thyroid Carcinoma in Patients with Clinical Unilateral Papillary Thyroid Carcinoma: A Case-Control Study
    Liu, Yihao
    Li, Shuo
    Xi, Pu
    Wang, Zipeng
    Sun, Hanlin
    Chang, Qungang
    Wang, Yongfei
    Yin, Detao
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2022, 2022
  • [9] Thyroid Lobectomy for T1 Papillary Thyroid Carcinoma in Pediatric Patients
    Sudoko, Chad K.
    Jenks, Carolyn M.
    Bauer, Andrew J.
    Isaza, Amber
    Mostoufi-Moab, Sogol
    Surrey, Lea F.
    Bhatti, Tricia R.
    Franco, Aime
    Adzick, N. Scott
    Kazahaya, Ken
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2021, 147 (11) : 943 - 950
  • [10] Optimal Serum Thyrotropin Level for Patients with Papillary Thyroid Carcinoma After Lobectomy
    Xu, Siyuan
    Huang, Ying
    Huang, Hui
    Zhang, Xiaohang
    Qian, Jiaxin
    Wang, Xiaolei
    Xu, Zhengang
    Liu, Shaoyan
    Liu, Jie
    THYROID, 2022, 32 (02) : 138 - 144